These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 8403390
1. Detection and characterization of blocking-type anti-acetylcholine receptor antibodies in sera from patients with myasthenia gravis. Hara H, Hayashi K, Ohta K, Itoh N, Nishitani H, Ohta M. Clin Chem; 1993 Oct; 39(10):2053-7. PubMed ID: 8403390 [Abstract] [Full Text] [Related]
2. Acetylcholine receptor antibody characteristics in myasthenia gravis. Fractionation of alpha-bungarotoxin binding site antibodies and their relationship to IgG subclass. Whiting PJ, Vincent A, Newsom-Davis J. J Neuroimmunol; 1983 Aug; 5(1):1-9. PubMed ID: 6874919 [Abstract] [Full Text] [Related]
3. Heterogeneity of antibodies directed against the alpha-bungarotoxin binding site on human acetylcholine receptor and severity of myasthenia gravis. Vernet-der Garabedian B, Morel E, Bach JF. J Neuroimmunol; 1986 Jul; 12(1):65-74. PubMed ID: 3711314 [Abstract] [Full Text] [Related]
4. Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors. Kirchner T, Tzartos S, Hoppe F, Schalke B, Wekerle H, Müller-Hermelink HK. Am J Pathol; 1988 Feb; 130(2):268-80. PubMed ID: 2449082 [Abstract] [Full Text] [Related]
5. Rhabdomyosarcoma cell line can be used for the isolation of soluble acetylcholine receptor and for assaying blocking and modulating autoantibodies. Wu JT, Astill M, Lloyd C, Salmon VC. J Clin Lab Anal; 1993 Feb; 7(1):11-8. PubMed ID: 8426270 [Abstract] [Full Text] [Related]
6. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies. Rigamonti A, Lauria G, Piamarta F, Fiumani A, Agostoni E. J Neurol Sci; 2011 Mar 15; 302(1-2):112-3. PubMed ID: 21236448 [Abstract] [Full Text] [Related]
7. Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis. Ohta M, Itoh M, Hara H, Itoh N, Nishitani H, Hayashi K, Ohta K. Clin Chim Acta; 1991 Sep 30; 201(3):201-5. PubMed ID: 1756593 [Abstract] [Full Text] [Related]
8. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor. Maggi L, Andreetta F, Antozzi C, Confalonieri P, Cornelio F, Scaioli V, Mantegazza R. Neuromuscul Disord; 2008 Aug 30; 18(8):678-80. PubMed ID: 18657424 [Abstract] [Full Text] [Related]
12. Myasthenogenic significance of synthetic alpha-subunit peptide 183-200 of Torpedo californica and human acetylcholine receptor. Takamori M, Okumura S, Nagata M, Yoshikawa H. J Neurol Sci; 1988 Jun 30; 85(2):121-9. PubMed ID: 3260271 [Abstract] [Full Text] [Related]
13. [Heterogeneity of antibodies blocking the binding of bungarotoxin to the acetylcholine receptor in myasthenia]. Vernet-der-Garabédian B, Morel E, Bach JF. C R Acad Sci III; 1984 Jun 30; 298(16):449-56. PubMed ID: 6428718 [Abstract] [Full Text] [Related]
14. Immunological specificity and cross-reactivity of anti-acetylcholine receptor and anti-presynaptic membrane receptor antibodies in myasthenia gravis. Xiao BG, Lu CZ, Höjeberg B, Link H. J Neurol Sci; 1991 Sep 30; 105(1):118-23. PubMed ID: 1665503 [Abstract] [Full Text] [Related]
19. Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus. Schwimmbeck PL, Dyrberg T, Drachman DB, Oldstone MB. J Clin Invest; 1989 Oct 30; 84(4):1174-80. PubMed ID: 2551924 [Abstract] [Full Text] [Related]